Table 1.
Gender | |
Male | 253 |
Female | 272 |
Age (years) | |
Median | 58 |
Range | 18–85 |
Cancer groups (%) | |
Gastrointestinal | 161 (30.7) |
Melanoma | 113 (21.5) |
Genitourinary | 47 (9.0) |
Head and neck | 37 (7.0) |
Breast | 37 (7.0) |
Gynecological | 34 (6.5) |
Thyroid | 27 (5.1) |
Lung | 26 (5.0) |
Sarcoma | 26 (5.0) |
Neuroendocrine | 7 (1.3) |
Lymphoma | 5 (1.0) |
Unknown primary | 3 (0.6) |
Neurofibromatosis | 1 (0.2) |
Thymoma | 1 (0.2) |
No. of prior therapies | |
Median | 4 |
Range | 0–15 |
Associated cardiovascular comorbidities, n (%) | |
0 | 192 (37) |
1 | 188 (35) |
2 | 103 (20) |
3 | 31 (6) |
4 | 11 (2) |